Controversy Erupts Over the New Cardiac Risk Calculator

Last week, when the new AHA/ACC guidelines on cholesterol treatment were released, I predicted that controversy would erupt over the new risk-calculator that was released as part of the guidelines.  This risk-calculator, which will help determine whether statin therapy ought to be used to reduce your cardiac risk, appears flawed....Read Full Post
Source: About.com Heart Disease - Category: Cardiology Source Type: blogs